HOME >> BIOLOGY >> NEWS
Stem cell specialists face questioning

A top panel of experts will face questions of public and scientific concern on stem cell research during an international conference being held at The University of Manchester this week.

The Stem Cell Question Time will be headed by Lord Naren Patel, chair of the UK National Stem Cell Network, as part of Stem Cell Manchester, a three-day gathering of stem cell researchers from across the globe.

Among the panellists at Wednesdays event will be Ron McKay from the National Institutes of Health, Bethesda, USA, Justine Burley, from the University of Singapore, and Jed Davies, from the University of Toronto, Canada.

The audience, which will be comprised of scientists both within and outside the field, will be invited to submit questions on important, contentious and challenging issues facing the stem cell research community.

Such topics up for discussion are likely to focus on the ethical issues surrounding stem cell research as well as the scientific challenges that must be overcome if this cutting-edge branch of biomedical research is to fulfil its true potential.

Also on the panel are Alan Coleman, from Embryonic Stem Cell International, Singapore, Chris Mason, from University College, London, and Daniel Brison, Co-director of the Northwest Embryonic Stem Cell Research Centre based at St Marys Hospital and The University of Manchester.

The Stem Cell Manchester conference has attracted leading figures in stem cell research from across the world, said organiser Professor Tim Hardingham, who is based in Manchesters Faculty of Life Sciences.

We have a packed programme of speakers lined up over the next few days culminating with the Question Time event on Wednesday where people outside the field can take part in a full and frank debate of the issues surrounding stem cell research.

Among the speakers at the conference is Shinya Yamanaka, whose team at Kyoto University in Japan is pioneering wa
'"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
16-Jul-2007


Page: 1 2

Related biology news :

1. Heart specialists call for cardiovascular screening for all young competitive athletes
2. Bone specialists hi-tech answer to patient care
3. NNii media advisory about David Kirbys book questioning vaccine safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
(Date:6/23/2016)... June 23, 2016 On Wednesday, June ... 4,833.32, down 0.22%; the Dow Jones Industrial Average edged 0.27% ... at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage on the ... Nektar Therapeutics (NASDAQ: NKTR ), Aralez Pharmaceuticals Inc. ... BIND ). Learn more about these stocks by ...
Breaking Biology Technology:
Cached News: